Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Luveniq voclosporin: Clinical trial preliminary data

Preliminary data from 7 patients with active lupus nephritis in the open-label, Malaysian AURION trial showed that twice-daily 23.7 mg oral voclosporin plus mycophenolate mofetil (MMF)

Read the full 261 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE